Cargando…

Thromboelastometry for Assessing Risks of Free Flap Thrombosis in Patients Undergoing Microvascular Surgery

Introduction: Coagulation assessment is often missing in microvascular surgery. We aimed at evaluating the predictive value of thromboelastometry for free flap thrombosis in microvascular surgery patients. Materials and Methods: We enrolled 103 adult patients with traumatic injuries scheduled for mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanags, Indulis, Stepanovs, Jevgenijs, Ozolina, Agnese, Mukans, Maksims, Bjertnaes, Lars J., Mamaja, Biruta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324680/
https://www.ncbi.nlm.nih.gov/pubmed/32656219
http://dx.doi.org/10.3389/fmed.2020.00289
_version_ 1783551989470199808
author Vanags, Indulis
Stepanovs, Jevgenijs
Ozolina, Agnese
Mukans, Maksims
Bjertnaes, Lars J.
Mamaja, Biruta
author_facet Vanags, Indulis
Stepanovs, Jevgenijs
Ozolina, Agnese
Mukans, Maksims
Bjertnaes, Lars J.
Mamaja, Biruta
author_sort Vanags, Indulis
collection PubMed
description Introduction: Coagulation assessment is often missing in microvascular surgery. We aimed at evaluating the predictive value of thromboelastometry for free flap thrombosis in microvascular surgery patients. Materials and Methods: We enrolled 103 adult patients with traumatic injuries scheduled for microvascular free flap surgery into a prospective observational study. Thirty-six patients with recent trauma underwent surgery within 30 days (ES group), and were compared with 67 trauma patients who underwent surgery later than 30 days (late surgery, LS group) after the injury. Rotational thromboelastometry (RTE) was performed before surgery. Functional fibrinogen to platelet ratio (FPR) ≥ 42 was selected as the main hypercoagulability index. Free flap thrombosis was set as primary outcome. Thrombotic risk factors and duration of surgery related to free flap thrombosis were secondary outcomes. Statistical significance p < 0.05; not significant NS. Results: Six patients (16.7%) in the ES group and 10 (14.9%) in the LS group had free flap thrombosis (NS). In the entire cohort, free flap thrombosis rate increased in the presence of thrombogenic comorbidities (OR 4.059, CI 1.33–12.37; p = 0.014) and prolonged surgery times (OR 1.007, CI 1 – 1.012; p = 0.05). Although hypercoagulability occurred more frequently in the ES group (44.4%) than in the LS group (11.9%; p < 0.001), it was not associated with higher free flap thrombosis rate. In ES group patients with surgery times > 240 min, the risk of free flap thrombosis increased (OR 3.5, CI 1.16-10.6; p = 0.026) with 93.3% sensitivity and 86.7% specificity (AUC 0.85; p = 0.007). In contrast, in LS patients hypercoagulability increased the odds of free flap thrombosis (OR 8.83, CI 1.74–44.76; p = 0.009). Moreover, a positive correlation was found between FPR ≥ 42 and free flap thrombosis rate (r = 0.362; p = 0.003). In the LS group, the presence of thrombogenic comorbidities correlated with free flap thrombosis rate (OR 7, CI 1.591–30.8; p = 0.01). Conclusions: In LS patients with thrombogenic comorbidities, thromboelastometry supports the detection of hypercoagulability and predicts free flap thrombosis risk. In ES patients, postoperative hypercoagulability did not predict free flap thrombosis. Prolonged surgery time should be considered as a risk factor.
format Online
Article
Text
id pubmed-7324680
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73246802020-07-10 Thromboelastometry for Assessing Risks of Free Flap Thrombosis in Patients Undergoing Microvascular Surgery Vanags, Indulis Stepanovs, Jevgenijs Ozolina, Agnese Mukans, Maksims Bjertnaes, Lars J. Mamaja, Biruta Front Med (Lausanne) Medicine Introduction: Coagulation assessment is often missing in microvascular surgery. We aimed at evaluating the predictive value of thromboelastometry for free flap thrombosis in microvascular surgery patients. Materials and Methods: We enrolled 103 adult patients with traumatic injuries scheduled for microvascular free flap surgery into a prospective observational study. Thirty-six patients with recent trauma underwent surgery within 30 days (ES group), and were compared with 67 trauma patients who underwent surgery later than 30 days (late surgery, LS group) after the injury. Rotational thromboelastometry (RTE) was performed before surgery. Functional fibrinogen to platelet ratio (FPR) ≥ 42 was selected as the main hypercoagulability index. Free flap thrombosis was set as primary outcome. Thrombotic risk factors and duration of surgery related to free flap thrombosis were secondary outcomes. Statistical significance p < 0.05; not significant NS. Results: Six patients (16.7%) in the ES group and 10 (14.9%) in the LS group had free flap thrombosis (NS). In the entire cohort, free flap thrombosis rate increased in the presence of thrombogenic comorbidities (OR 4.059, CI 1.33–12.37; p = 0.014) and prolonged surgery times (OR 1.007, CI 1 – 1.012; p = 0.05). Although hypercoagulability occurred more frequently in the ES group (44.4%) than in the LS group (11.9%; p < 0.001), it was not associated with higher free flap thrombosis rate. In ES group patients with surgery times > 240 min, the risk of free flap thrombosis increased (OR 3.5, CI 1.16-10.6; p = 0.026) with 93.3% sensitivity and 86.7% specificity (AUC 0.85; p = 0.007). In contrast, in LS patients hypercoagulability increased the odds of free flap thrombosis (OR 8.83, CI 1.74–44.76; p = 0.009). Moreover, a positive correlation was found between FPR ≥ 42 and free flap thrombosis rate (r = 0.362; p = 0.003). In the LS group, the presence of thrombogenic comorbidities correlated with free flap thrombosis rate (OR 7, CI 1.591–30.8; p = 0.01). Conclusions: In LS patients with thrombogenic comorbidities, thromboelastometry supports the detection of hypercoagulability and predicts free flap thrombosis risk. In ES patients, postoperative hypercoagulability did not predict free flap thrombosis. Prolonged surgery time should be considered as a risk factor. Frontiers Media S.A. 2020-06-23 /pmc/articles/PMC7324680/ /pubmed/32656219 http://dx.doi.org/10.3389/fmed.2020.00289 Text en Copyright © 2020 Vanags, Stepanovs, Ozolina, Mukans, Bjertnaes and Mamaja. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Vanags, Indulis
Stepanovs, Jevgenijs
Ozolina, Agnese
Mukans, Maksims
Bjertnaes, Lars J.
Mamaja, Biruta
Thromboelastometry for Assessing Risks of Free Flap Thrombosis in Patients Undergoing Microvascular Surgery
title Thromboelastometry for Assessing Risks of Free Flap Thrombosis in Patients Undergoing Microvascular Surgery
title_full Thromboelastometry for Assessing Risks of Free Flap Thrombosis in Patients Undergoing Microvascular Surgery
title_fullStr Thromboelastometry for Assessing Risks of Free Flap Thrombosis in Patients Undergoing Microvascular Surgery
title_full_unstemmed Thromboelastometry for Assessing Risks of Free Flap Thrombosis in Patients Undergoing Microvascular Surgery
title_short Thromboelastometry for Assessing Risks of Free Flap Thrombosis in Patients Undergoing Microvascular Surgery
title_sort thromboelastometry for assessing risks of free flap thrombosis in patients undergoing microvascular surgery
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324680/
https://www.ncbi.nlm.nih.gov/pubmed/32656219
http://dx.doi.org/10.3389/fmed.2020.00289
work_keys_str_mv AT vanagsindulis thromboelastometryforassessingrisksoffreeflapthrombosisinpatientsundergoingmicrovascularsurgery
AT stepanovsjevgenijs thromboelastometryforassessingrisksoffreeflapthrombosisinpatientsundergoingmicrovascularsurgery
AT ozolinaagnese thromboelastometryforassessingrisksoffreeflapthrombosisinpatientsundergoingmicrovascularsurgery
AT mukansmaksims thromboelastometryforassessingrisksoffreeflapthrombosisinpatientsundergoingmicrovascularsurgery
AT bjertnaeslarsj thromboelastometryforassessingrisksoffreeflapthrombosisinpatientsundergoingmicrovascularsurgery
AT mamajabiruta thromboelastometryforassessingrisksoffreeflapthrombosisinpatientsundergoingmicrovascularsurgery